Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel mild preparation of antineoplastic drug tegafur using 2-benzoyloxy tetrahydrofuran. High yield, >99.7% purity, scalable industrial process.
Advanced phase transfer catalysis for isoflavone 7-O-glucosides. Delivers high yields, mild conditions, and scalable production for global supply chains.
Patent CN118271376A reveals a novel allyl sulfone glycosyl donor for high-yield thioglycoside synthesis. Discover cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN101381387A reveals a cost-effective, stereoselective route for Gemcitabine Hydrochloride, eliminating cryogenic conditions and improving supply chain reliability for API manufacturers.
Patent CN104926806B reveals a robust method for Lamivudine intermediates, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN112940053B reveals a streamlined route for anti-HCV drugs, offering high purity and industrial scalability for reliable supply chains.
Patent CN111454270A discloses a novel six-membered ring nucleoside synthesis. Offers improved solubility and scalable routes for antiviral API manufacturing.
Novel Ni(II)-catalyzed method for high stereoselectivity 1,2-cis-glycosides. Reduces steps, improves yield, offers cost-effective API intermediate manufacturing.
Patent CN109111490B introduces a novel halogenated pivaloyl glucopyranose route for SGLT2 inhibitors, offering superior stereoselectivity and industrial scalability for pharmaceutical manufacturing.
Patent CN110642897A reveals a novel, scalable synthesis for beta-nicotinamide riboside chloride. High-purity NRC precursor for NMN manufacturing without chromatography.
Patent CN111662260B reveals a 7-step synthesis of saffloneoside. Offers stable intermediates and scalable routes for cerebral ischemia drug development.
Novel synthesis route for 3-O-propargyl nucleoside avoids isomers ensuring high purity and scalable manufacturing for pharmaceutical intermediates globally.
Patent CN111233949A details a novel one-pot three-enzyme method for GM3 synthesis, offering high stereoselectivity and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN112159447B details a novel DMAP-catalyzed route for 2-chloroadenosine, offering superior purity and yield while eliminating heavy metal contamination for scalable API production.
Patent CN101497639B details a scalable Decitabine synthesis using toluoyl protection and fractional crystallization, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN113461743A reveals a cost-effective 4-step route for crosslinkable nucleosides, eliminating chromatography and enabling high-purity oligonucleotide manufacturing.
Patent CN107573311A reveals a cost-effective Dapagliflozin route using 4-methylphenol. This method ensures high purity and scalable manufacturing for global supply chains.
Patent CN108610386A reveals a scalable synthesis for hexuronic acid glycosides. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with our advanced catalytic process.
Patent CN101712705B details a robust synthetic route for apigenin glycosides, offering reliable supply chain solutions and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106279311B details a novel Gastrodin synthesis using montmorillonite and ceric ammonium nitrate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.